Get started
Author

Marouf Mouhammad Alhalabi

Observed names: Alhalabi Marouf, Alhalabi, Marofu, M Alhalabi, Marouf Alhalabi, Marouf M. Alhalabi, Marouf Mohammad Alhalabi, Marouf Muhammad Alhalabi, MaroufMuhammad Alhalabi
Institution: Damascus Hospital
Observed institution: Damascus Hospital
ORCID: 0000-0001-5027-2096
Observed ORCID: 0000-0001-5027-2096
OpenAlex ID: A5048700466
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
2018 · Khaled Mohammad Cheha, Sawsan Omar Ali Dib, et al. · Avicenna Journal of Medicine · 20
Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial
2021 · Marouf Alhalabi, Mohammed Waleed Alassi, et al. · BMC Infectious Diseases · 12
PDF
Mortality and risk factors associated with peptic ulcer bleeding among adult inpatients of Damascus Hospital, Syria: A cross-sectional study
2023 · Marouf Mouhammad Alhalabi · Medicine · 8
Portal vein thrombosis as extraintestinal complications of Crohn’s disease: a case report and review of literature
2024 · Marouf Alhalabi, Duaa Nasri, et al. · Journal of Medical Case Reports · 6
Ulcerative colitis-associated bronchiectasis: A rare extraintestinal manifestation of inflammatory bowel disease: A case report
2022 · Marouf Alhalabi, Sawsan Ali Deeb, et al. · Medicine · 6
The incidence of hepatitis B reactivation in patients receiving ustekinumab: a systematic review and proportional meta-analysis
2024 · Marouf M. Alhalabi, Rasha Almokdad · European Journal of Gastroenterology & Hepatology · 5
A diagnostic dilemma: cytomegalovirus colitis as an uncommon comorbidity in inflammatory bowel disease: a case report
2024 · Marouf Alhalabi, Soumar Mueen Alziadan · Virology Journal · 5
PDF
Advanced diffuse gastric adenocarcinoma in young Syrian woman. A case report
2022 · Marouf M. Alhalabi, Saddam A. Alsayd, et al. · Annals of Medicine and Surgery · 5
Prevalence of opportunistic infections in Syrian inflammatory bowel disease patients on biologic therapy: a multi-center retrospective cross-sectional study
2025 · Marouf Alhalabi, Hussam Aldeen Alshiekh, et al. · BMC Infectious Diseases · 4
PDF
Therapeutic effects of biological treatments on AA amyloidosis associated with inflammatory bowel disease: a case report and literature review
2023 · Marouf Alhalabi, Kamal Alaa Eddin, et al. · European Journal of Gastroenterology & Hepatology · 4
Allgrove syndrome: a case report
2022 · Marouf Alhalabi, Saddam Alsayd, et al. · Oxford Medical Case Reports · 3
PDF
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis
2022 · Marouf Alhalabi, Kamal Alaa Eddin, et al. · Medicine · 3
Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis
2021 · Marouf Alhalabi, Kamal Alaa Eddin, et al. · Medicine · 3
Risk of hepatitis B virus reactivation associated with interleukin inhibitor therapies: protocol for a systematic review and meta-analysis
2025 · Marouf Mouhammad Alhalabi, Hussam Aldeen Alshiekh · BMJ Open · 2
PDF
Hepatitis B reactivation with TNF-α inhibitors: assessing antiviral prophylaxis efficacy — protocol for systematic review and meta-analysis
2025 · Alhalabi Marouf, Sawan Sedra · Systematic Reviews · 2
PDF
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
2024 · Marouf Alhalabi, Rasha Almokdad · Trials · 2
PDF
Ustekinumab for steroid-refractory pancolitis in a biologically naive child: A case report and literature review
2023 · Marouf Alhalabi · Medicine · 2
Subcutaneous golimumab to treat a biological naïve chronically active ulcerative colitis child. A case report
2022 · Marouf M. Alhalabi, Ahmad J. Abbas · Annals of Medicine and Surgery · 2
PDF
Levofloxacin-based concomitant versus sequential therapy for Helicobacter pylori eradication in treatment-naïve Syrian patients: a randomized trial showing no superiority of sequential therapy
2026 · Marouf Alhalabi, Hussam Aldeen Alshiekh, et al. · Gut Pathogens
PDF
Budd-Chiari syndrome in inflammatory bowel disease: a case report and systematic review
2026 · Marouf Alhalabi, Sara Rustm, et al. · Open Science Framework
Transient sinus bradycardia complicating acute severe ulcerative colitis a case report and review of the literature
2026 · Marouf M. Alhalabi, Shadi Alsaiad, et al. · Discover Medicine
PDF
Hepatitis B Virus Reactivation Risk With IL ‐17, IL ‐23/ IL ‐12, or JAK Inhibitors: A Systematic Review and Meta‐Analysis
2026 · Marouf Alhalabi, Hussam Aldeen Alshiekh · Liver International
P1268 Impact of religion fasting on the condition of Inflammatory Bowel Disease: primary results of a multicenter multinational study
2026 · P Alavi Nejad, N Ebrahimi Daryani, et al. · Journal of Crohn s and Colitis
Methodological validity and analytical practices in meta-analyses of hepatitis B reactivation risk during biologic therapy: a systematic meta-research study
2026 · Alhalabi, Marofu, Alshiekh, Hussam Aldeen
Addressing the Critical Gap in Biological Therapies for Inflammatory Bowel Disease in Syria
2025 · Marouf Mouhammad Alhalabi · Avicenna Journal of Medicine
PDF
Works count: 36
Citation count: 94
H-index: 5
I10-index: 2
Year
Topic
Type